Main Category: Diabetes
Article Date: 15 Nov 2010 - 2:00 PST window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }());
email to a friend ? 
printer friendly ? 
opinions ? 
AMA President, Dr Andrew Pesce, said today that the AMA welcomes Health Minister Nicola Roxon's revised approach to implementing a new scheme for care for people with diabetes.
Dr Pesce said the Minister has consulted closely with the AMA and the medical profession and has proposed a trial of the scheme so it can be properly assessed and evaluated.
"The AMA supports good evidence being the basis for decisions on health policy," Dr Pesce said.
"Just as there are robust trials for clinical research there must be robust trials on health service policy, which incorporate valid and reliable methodology.
"The AMA did not believe there was a proper evidence base underpinning the Government's original proposal for care for people with diabetes.
"A reliable and valid trial will take the politics out of the debate and ensure that decisions on health service delivery are made based on evidence to support good patient outcomes.
"The AMA has agreed to be a member of a 'design group' to help put together, oversee, and evaluate the trial.
"We commend the Minister for seeking and including clinical input to this trial," Dr Pesce said.
Source:
Australian Medical Association
(Hover over the stars
then click to rate)
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
All opinions are moderated before being added.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
No comments:
Post a Comment